Alleh Lindquist

Alleh Lindquist is Chief Executive Officer of FloraWorks, where he focuses on advancing cannabinoid therapeutic research and developing clinically validated ingredients for use in regulated healthcare channels, including the first cannabinoid ingredient TruCBN™supported by randomized clinical data demonstrating improvement in sleep quality and a comprehensive safety package. He also serves on the board of Lidera Health, a clinical support platform supporting physician-led cannabinoid care, including patient monitoring, safety oversight, and real-world evidence generation. He is a member of the National Compassionate Care Council, a policy and advocacy organization focused on expanding access to cannabinoid therapies.